CD28 and rheumatoid arthritis: In some of them, they considered the differences between non-active RA and active RA, or the influence of some treatments, such as anti-TNFα or CD28 costimulation blocker, but only one of them analyzed this subpopulation in the early stages of the disease [8,11,12,32].